TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Credibility score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Live Female Adult Worms Without Wolbachia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinically significant changes in physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically significant changes in total (IgG) IDUA antibody titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinically significant changes in clinical laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically significant changes in treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Trial Outcome Index (TOI) score from the FACT-Lym
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participation rate of the atrial fibrillation and albuminuria screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Yield of the atrial fibrillation and albuminuria screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effectiveness of the atrial fibrillation screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of the albuminuria screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hamstrings maximal voluntary isometric contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quadriceps maximal voluntary isometric contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction of fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Participants with Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: change in dentin hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of limb ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Cancer and Aging Research Group (CARG) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GEP hotspot location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in optimal stimulation parameters at GEP hotspot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleeping quality change
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Absolute values of plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute values of serum insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute values of serum C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complete response status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasmatic free circulating DNA (cfDNA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Eczema Area Severity Index (EASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in Atopic Dermatitis Severity Index (ADSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Team leader performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Child Swim Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consent rate for germline testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Shame and distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Smartphone addiction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post-disclosure health behavior change as measured by the health behavior subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-disclosure health behavior change as measured by the health communication subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-disclosure health behavior change as measured by the advanced planning subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-disclosure health behavior change as measured by the research engagement subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent participant retention in University of Michigan Memory and Aging Project (UMMAP) study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from Baseline in explosive strength of lower limbs at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in body mass at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in systolic blood pressure at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diaphragm thickness fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute acalculous cholecystitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in fluorescein staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients progression-free and alive at six months
Endpoint domain: Mortality/survival
Primary endpoint: Change in pain as measured by the McGill Pain Questionnaire (MPQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in neuropathic pain as measured by the Neuropathic Pain Symptom Inventory (NPSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of tropical infectious diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Morbidity associated with tropical infectious diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Transmission of tropical infectious diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time-weighted average change in HRV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the combined exercise program
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in movement-evoked pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Absolute Prediction Error (D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development Coordination Disorder Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mental effects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical effects
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Socio-economic effects
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Composite of delirium or AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Re-operation for bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidences of Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Couple Relationship/Co-parenting
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Parent Adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent Alcohol Use
Endpoint domain: Adverse events/effects
Primary endpoint: Hematoma presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Speech perception testing in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potentially Inappropriate Medication
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of all-cause mortality or heart failure related rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: FEV1 annual decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: maximal isometric joint flexion muscle strength MTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Interpregnancy interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: State and trait anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of SARS-CoV-2-associated invasive aspergillosis
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of pitted lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Malaria infection incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Resolution of pregnancy loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Tumor Necrosis Factor-alpha (TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Interferon-gamma (IFN-γ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of acute and early late genitourinary, gastrointestinal and sexual toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained Relief from NV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inspiratory flow from upper airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tidal volume from upper airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tran-tracheal pressure (TTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in erythema score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Electromyographic muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of mandibular movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical field visibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in knee pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Outcomes of AKI in patients with DKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: aMCI (Amnestic Mild Cognitive Impairment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain Functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ANS (Autonomic Nervous System) stress analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Identification of Rare Genetic Variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of somatic (tumor only) mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of Rare Genetic Variant in family members
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to rewarm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of Staccato alprazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central Vestibular Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective Visual Vertical (SVV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ocular Vestibular Evoked Myogenic Potential (oVEMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Semi-circular canal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cervical Vestibular Evoked Myogenic Potential (cVEMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number and severity of participants with Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number and severity of participants with Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Zero to Infinity (AUC[0-∞])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MR acquisition and reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAS score improvement at Wrist Flexor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery of low-birthweight infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Breastfeeding self-efficacy change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breastfeeding success change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in brain structures on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Scapular kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Shoulder kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Electrocardiography (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anticoagulation Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child's behavior during dental visit
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of one or more grade 3 or higher adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Inhaler technique assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing rates (percent area reduction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Sculptra Aesthetic
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Numeric Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of persons with ≥ 1 neoplastic lesion detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Autism Diagnostic Observation Schedule-Second Edition (ADOS-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Griffith Scale Development Scales (GMDS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vineland Adaptive Behavior Scales (VABS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Weight management during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acceptance of multi-site samples
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first cardiovascular-related consultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first cardiovascular-related diagnostic testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first cardiovascular-related hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first cardiovascular-related drug prescription
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Retina Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical Plaque Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Past-month vaping days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cfPWV measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pulse wave analysis (PWA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived Feature Usefulness Scale (PFU)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Technology Acceptance Based Model Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child utterance complexity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age at first words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of facial emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Metacognitive sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Wound Closure Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration of vasopressors and inotropes infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quantification of Selected Pharmacodynamic Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diet composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall Tolerability of CD19x22 CAR T Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of CR, PR, SD, and PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reporting ORR, PFS, DOR, and OS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in social support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Accuracy of the algorithm for predicting liver decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: time to cessation of vital support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total vasopressor-inotrope dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in MADRS-rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of improvement of wart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Multiple Object Tracking (MOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edgren Side Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ottawa sitting scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: System Usability Scale of Cognition Management Tasks (SUS CMTs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-Efficacy of Cognition Management Tasks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with mRS score 0-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Red cell concentrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: frequency of hypothermia
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal elevation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bathroom use
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: treatment complete rate (TCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in resting PPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new biopsy confirmed BCCs that develop on the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of dermatological, treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Expanded Disability Status Scale Score (EDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new, and/or enlarging T2- hyperintense lesions detected by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: changes in protruded/extruded disc size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NT-proB-type Natriuretic Peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of subjects experiencing a primary safety event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects with acute procedure success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes